Cargando…
Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
OBJECTIVES: Although not licensed for acute bipolar depression, lamotrigine has evidence for efficacy in trials and its use is recommended in guidelines. So far there had been no prospective health economic evaluation of its use. METHODS: Cost‐utility analysis of the CEQUEL trial comparing quetiapin...
Autores principales: | Simon, Judit, Geddes, John R., Gardiner, Alexandra, Rendell, Jennifer, Goodwin, Guy M., Mayer, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491973/ https://www.ncbi.nlm.nih.gov/pubmed/30375699 http://dx.doi.org/10.1111/bdi.12713 |
Ejemplares similares
-
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
por: Tunbridge, EM, et al.
Publicado: (2017) -
Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008) -
Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
por: Maneeton, Benchalak, et al.
Publicado: (2017) -
Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019) -
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
por: Young, Allan H, et al.
Publicado: (2013)